About Us
2020
  
2020

In 2020, during the COVID-19 pandemic, the nucleic acid extraction and PCR instruments and reagents independently developed and produced by Tianlong have greatly contributed to the prevention and control of the epidemic situations domestically and globally.

2019
  
2019

In 2019, the 'Fluorescent Digital Gene Amplification Single Molecule Detector' Project led by Tianlong, of the National Key R&D Program of China, was successfully launched in Xi'an, China.


2018
  
2018

In 2018, Tianlong, with its own sustainable development value, obtained a strategic investment from Shanghai Kehua Bio-Engineering co., Ltd. (stock code:  002022). 


2016
  
2016

In 2016, Tianlong's Intelligent Medical Equipment R&D and Production Project of Independent Medical Laboratory Equipment and Reagents Production Project, i.e. the Medical Health Industrial Park, officially laid the foundation stone.


2015
  
2015

In 2015, Tianlong invested in Wuxi Ruiqi Gene Biotechnology Co., and started the new era of personalized precision medicine.  


2014
  
2014

In 2014, Tianlong developed the Ebola virus nucleic acid testing kits to help prevent and control the Ebola epidemic in Africa.


2013
  
2013

In 2013, the project of development and application of automated quantitative detection and high-resolution analysis equipment for nucleic acids, as a National Special Project for the Development of Major Scientific Instruments and Equipment, was officially launched.


2012
  
2012

In 2012, Tianlong received investment from SK Group, the 57th in the Fortune Global 500 list.


2009
  
2009

In 2009, Suzhou Tianlong Biotechnology Co. was established. 

In 2009, the first case of H1N1 was detected in Shaanxi Province by Tianlong, then thousands of cases of influenza A were confirmed in China by us.


2007
  
1997-2007

In 2007, the projects of microsystems for detection and early warning of major diseases, and portable molecular biochemical detector, as part of National High-tech R&D Program (863 Program), were presided over by Tianlong.


In 2003, Xi'an Tianlong was approved as the first batch of medical device (Class III) manufacturers in China.


In 1997, Xi'an Tianlong Technology Co., Ltd. was established.